Navigation Links
How Patients Can Meet the Criteria for Insulin Pump Therapy
Date:4/8/2008

Convincing health insurers of the benefit of pump technology is biggest

hurdle

PORTLAND, Ore., April 8, 2008 /PRNewswire/ -- While many health plan insurers will pay for patients with type 1 diabetes mellitus to have an insulin pump, the criteria for approval is not always clear.

"Continuous subcutaneous insulin infusion (CSII) or insulin pump therapy is an ideal tool for the patient in need of intensive insulin therapy and carbohydrate counting," explains Dr. Skip Freedman, Executive Medical Director at AllMed Healthcare Management, a leading independent review organization (IRO). "But only when they can also put in the time and effort needed to use a pump effectively. In general, patients need a pump when they cannot achieve acceptable control using a regimen of multiple daily injections or when they have frequent hypoglycemic episodes or hypoglycemic unawareness."

Accepted Guidelines

The American Association of Clinical Endocrinologists (AACE) current guidelines recommend insulin pump use for patients who are willing and able to comply with prescribed type 1 diabetes mellitus self-care behavior that includes frequent monitoring of blood sugars, carbohydrate counting and insulin adjustment. This implies that CSII is not only appropriate as a last-ditch effort when all else fails for the patient, but is also appropriate for any patient who is complying with the general recommendations for good type 1 diabetes care.

According to Freedman, patients who are unable to achieve acceptable control using a regimen of multiple daily injections and patients with frequent hypoglycemic episodes or hypoglycemic unawareness should discuss the value of an insulin pump with their doctors. Patients who are very insulin sensitive; those unable to sense when blood sugars are too low; and those with high morning blood sugars often can benefit from the ability of a pump to adjust their insulin rates hour by hour.

Criteria to Meet

Most health insurers and third-party payers will reimburse for an insulin pump if the patient meets specific criteria. They require that the patient has type 1 diabetes (or at least is insulinopenic by c-peptide, medicare criteria with a c-peptide less than 110 percent of the upper limit of normal with a simultaneous glucose of less than 225 mg/dl). In addition, a patient must be under the care of an endocrinologist who manages patients on pumps. And, the patient must be taking at least four shots of insulin a day, monitoring their blood sugars at least four times a day and still not meeting glycemic control goals. Usually these goals are:

-- having an A1C (also known as glycated hemoglobin or HbA1c) of less

than 7 percent,

-- avoiding hypoglycemia and

-- avoiding high morning blood sugars (also called dawn phenomenon).

"A patient also needs to complete an education program that usually includes how to use and operate the pump and perform carbohydrate counting," said Dr. Freedman. "Few patients with type 1 diabetes mellitus meet all three of theses goals all the time. So the decision usually comes down to determining whether the patient has been on a reasonable insulin regimen and is compliant with home monitoring."

The biggest challenge that endocrinologists face today is convincing health insurers and third-party payers about the benefits of pump technology. However, this is becoming easier because increasingly studies show the benefits of controlling the frequency of hypoglycemia and hyperglycemia, as well as improving A1C values.

For more information on leading-edge treatments and their medical necessity, check out http://www.allmedmd.com/peerpoints/cuttingedge/cutting_edge_email.htm. To find out more about the medical review services that IROs offer, go to AllMed's Website at http://www.allmedmd.com.


'/>"/>
SOURCE AllMed Healthcare Management
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Compensation Research Institute (WCRI) officially opened registration today for its 33rd Annual ... in Boston, MA . , The theme of the conference is “Persistent Challenges ...
(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ... and patients about the safety issues related to dental restorations. According to the American ... projected to reach $6.4 billion in 2018 with more than 30 million Americans missing ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software ... and employees that are both engaging and easy to use. Coming off the ... software company revealed today its plans to roll out new AI-powered self-service enhancements ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Australia Glaucoma Surgery Devices Market Outlook ... "Australia Glaucoma Surgery Devices Market Outlook to 2022", ... Surgery Devices market. The report provides value, in ... average prices (USD) within market segement - Glaucoma ... shares and distribution shares data for each of ...
(Date:12/8/2016)... KEY FINDINGS The global medical lifting sling ... for growth of the medical lifting sling market are ... high recovery cost of injuries and government initiatives to ... refers to an assistive device that helps caregiver transfer ... the lift and hold the patient. It is important ...
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
Breaking Medicine Technology: